Director Scott M. Sperling Acquires Phantom Stock Units in Thermo Fisher Scientific ($TMO)
THERMO FISHER SCIENTIFIC INC.
Subscribe to track TMO
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Insider Transaction Alert: Thermo Fisher Scientific Inc. ($TMO) • Insider: Scott M. Sperling (Director) • Transaction: Acquisition (Deferred Compensation Plan) • Security: Phantom Stock Units • Shares: 62.96 @ $675.00 (~$42,498 total value) • Post-Transaction Holdings: 17,737.6 units • Significance: Low (Routine quarterly director fee deferral)
Comprehensive Analysis
Executive Summary
On September 26, 2026, Scott M. Sperling, a Director of Thermo Fisher Scientific Inc. ($TMO), acquired 62.96 Phantom Stock Units at a price of $675.00 per unit, representing a total transaction value of approximately $42,498. Following this transaction, Mr. Sperling holds 17,737.6 Phantom Stock Units directly.
Transaction Details
- Security: Phantom Stock Units (convertible into Common Stock on a 1-for-1 basis)
- Transaction Code: A (Award/Grant)
- Number of Shares/Units: 62.96
- Price Per Unit: $675.00
- Ownership Nature: Direct
- Post-Transaction Ownership: 17,737.6 units
Context & Significance
According to the footnotes, this transaction represents units credited pursuant to the Issuer's Deferred Compensation Plan for Directors. Under this plan, quarterly director retainers are automatically deferred into Common Stock units based on the quarter-end closing price. The shares become distributable upon cessation of service as a director or upon a change in control.
Because this acquisition is a routine, formulaic deferral of director compensation rather than an open-market, discretionary purchase, it carries Low trading significance.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.
